Health Care Journals | Open Access - Edelweiss | Edelweiss Publications

Journal of Obesity and Diabetes (ISSN: 2638-812X)

Keywords

Anti-obesity medication

Anti-obesity medication/weight loss drugs are pharmacological agents which reduce to control weight. The main treatment for overweight and obese to do regular dieting and physical exercise.

Anti-obesity medication drugs alter one of the fundamental processes of the body, weight regulation, by altering either appetite or absorption of calories.

Iorlistat (Xenical) is currently approved by the FDA for long-term use as it reduces intestinal fat absorption by inhibiting pancreatic lipase.

Rimonabant (Acomplia) works by specific blockage of the endocannabinoid system. Sibutramine (Meridia) which inhibit deactivation of the neurotransmitters, thereby decreasing appetite in the brain.

Journal of Obesity and Diabetes emphasize in publishing the original scholarly articles related to Obesity and Diabetes worldwide. The journal follows rapid review process with the Eminent Editorial Board

Editorial Board

Jhon Smith

Professor

editor
Jhon Smith

Professor

editor
Jhon Smith

Professor

editor
Jhon Smith

Professor

editor